Antioxidant and acetylcholinesterase inhibitory activities of ginger root (Zingiber officinale Roscoe) extract (original) (raw)

Abstract

Background

Zingiber officinale Roscoe has been used in traditional medicine for the treatment of neurological disorder. This study aimed to investigate the phenolic contents, antioxidant, acetylcholinesterase enzyme (AChE) inhibitory activities of different fraction of Z. officinale root grown in Vietnam.

Methods

The roots of Z. officinale are extracted with ethanol 96 % and fractionated with n-hexane, ethyl acetate (EtOAc) and butanol (BuOH) solvents. These fractions evaluated the antioxidant activity by 1,1-Diphenyl -2-picrylhydrazyl (DPPH) assay and AChE inhibitory activity by Ellman’s colorimetric method.

Results

Our data showed that the total phenolic content of EtOAc fraction was highest equivalents to 35.2±1.4 mg quercetin/g of fraction. Our data also demonstrated that EtOAc fraction had the strongest antioxidant activity with IC50 was 8.89±1.37 µg/mL and AChE inhibitory activity with an IC50 value of 22.85±2.37 μg/mL in a dose-dependent manner, followed by BuOH fraction and the n-hexane fraction is the weakest. Detailed kinetic analysis indicated that EtOAc fraction was mixed inhibition type with Ki (representing the affinity of the enzyme and inhibitor) was 30.61±1.43 µg/mL.

Conclusions

Our results suggest that the EtOAc fraction of Z. officinale may be a promising source of AChE inhibitors for Alzheimer’s disease.

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
  2. Research funding: None declared.
  3. Employment or leadership: None declared.
  4. Honorarium: None declared.
  5. Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. Essa MM, Vijayan RK, Castellano-Gonzalez G, Memon MA, Braidy N, Guillemin GJ. Neuroprotective effect of natural products against Alzheimer’s disease. Neurochem Res. 2012;37:1829–1842 PubMed PMID: 22614926.10.1007/s11064-012-0799-9Search in Google Scholar PubMed

2. Blennow K, De Leon MJ, Zetterberg H. Alzheimer’s disease. The Lancet. 2006;368:387–403.10.1016/S0140-6736(06)69113-7Search in Google Scholar

3. Harman D. The aging process. Proc Natl Acad Sci. 1981;78:7124–7128.10.1073/pnas.78.11.7124Search in Google Scholar PubMed PubMed Central

4. Lovell MA, Markesbery WR. Oxidative DNA damage in mild cognitive impairment and late-stage Alzheimer’s disease. Nucleic Acids Res. 2007;35:7497–7504.10.1093/nar/gkm821Search in Google Scholar PubMed PubMed Central

5. Grundman M, Delaney P. Antioxidant strategies for Alzheimer’s disease. Proc Nutr Soc. 2002;61:191–202.10.1079/PNS2002146Search in Google Scholar PubMed

6. Staehelin HB. Micronutrients and Alzheimer’s disease. Proc Nutr Soc. 2005;64:565–570.10.1079/PNS2005459Search in Google Scholar PubMed

7. Cutler N, Polinsky R, Srarnek J, Enz A, Jhee S, Mancione L, et al. Dose‐dependent CSF acetylcholinesterase inhibition by SDZ ENA 713 in Alzheimer’s disease. Acta Neurol Scand. 1998;97:244–250.10.1111/j.1600-0404.1998.tb00645.xSearch in Google Scholar PubMed

8. Bartus RT, Dean RL, Pontecorvo MJ, Flicker C. The cholinergic hypothesis: A historical overview, current perspective, and future directions. Ann N Y Acad Sci. 1985;444:332–358.10.1111/j.1749-6632.1985.tb37600.xSearch in Google Scholar PubMed

9. Williams P, Sorribas A, Howes M-JR. Natural products as a source of Alzheimer’s drug leads. Nat Prod Rep. 2011;28:48–77.10.1039/C0NP00027BSearch in Google Scholar PubMed

10. Ali BH, Blunden G, Tanira MO, Nemmar A. Some phytochemical, pharmacological and toxicological properties of ginger (Zingiber officinale Roscoe): A review of recent research. Food Chem Toxicol. 2008;46:409–420.10.1016/j.fct.2007.09.085Search in Google Scholar PubMed

11. Mathew M, Subramanian S. In vitro evaluation of anti-Alzheimer effects of dry ginger (Zingiber officinale Roscoe) extract. Indian J Exp Biol. 2014; Jun;52(6):606–612.Search in Google Scholar PubMed

12. Oboh G, Ademiluyi AO, Akinyemi AJ. Inhibition of acetylcholinesterase activities and some pro-oxidant induced lipid peroxidation in rat brain by two varieties of ginger (Zingiber officinale). Exp Toxicol Pathol. 2012;64:315–319.10.1016/j.etp.2010.09.004Search in Google Scholar PubMed

13. Azeez L, Badiru R. Antioxidant activity and phytochemical contents of some selected Nigerian fruits and vegetables. Am J Chem. 2012;2:209–213.10.5923/j.chemistry.20120204.04Search in Google Scholar

14. Koleva II, Van Beek TA, Linssen JP, Groot A, Evstatieva LN. Screening of plant extracts for antioxidant activity: A comparative study on three testing methods. Phytochem Anal. 2002;13:8–17.10.1002/pca.611Search in Google Scholar PubMed

15. Mensor LL, Menezes FS, Leitão GG, Reis AS, Santos T, Coube CS, et al. Screening of Brazilian plant extracts for antioxidant activity by the use of DPPH free radical method. Phytother Res. 2001;15:127–130.10.1002/ptr.687Search in Google Scholar PubMed

16. Ellman GL, Courtney KD, Andres V, Featherstone RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol. 1961;7:88–95.10.1016/0006-2952(61)90145-9Search in Google Scholar PubMed

17. Kamal MA, Greig NH, Alhomida AS, Al-Jafari AA. Kinetics of human acetylcholinesterase inhibition by the novel experimental Alzheimer therapeutic agent, tolserine. Biochem Pharmacol. 2000;60:561–570.10.1016/S0006-2952(00)00330-0Search in Google Scholar PubMed

18. Smith MA, Rottkamp CA, Nunomura A, Raina AK, Perry G. Oxidative stress in Alzheimer’s disease. Biochim Biophys Acta Mol Basis Dis. 2000;1502:139–144.10.1016/S0925-4439(00)00040-5Search in Google Scholar

19. Gray SL, Anderson ML, Crane PK, Breitner J, McCormick W, Bowen JD, et al. Antioxidant vitamin supplement use and risk of dementia or Alzheimer’s disease in older adults. J Am Geriatr Soc. 2008;56:291–295.10.1111/j.1532-5415.2007.01531.xSearch in Google Scholar PubMed

20. Kása P, Rakonczay Z, Gulya K. The cholinergic system in Alzheimer’s disease. Prog Neurobiol. 1997;52:511–535.10.1016/S0301-0082(97)00028-2Search in Google Scholar PubMed

21. Bone K, Mills S. Principles and practice of phytotherapy: Modern herbal medicine. Churchill Livingstone: Elsevier Health Sciences, 2013 .Search in Google Scholar

22. Yeh H-Y, Chuang C-H, Chen H-C, Wan C-J, Chen T-I, Lin L-Y. Bioactive components analysis of two various gingers (Zingiber officinale Roscoe) and antioxidant effect of ginger extracts. LWT-Food Sci Technol. 2014;55:329–334.10.1016/j.lwt.2013.08.003Search in Google Scholar

23. Choudhari S, Kareppa B. Identification of bioactive compounds of Zingiber Officinale Roscoe Rhizomes through gas chromatography and mass spectrometry. Int J Pharm Res Dev. 2013;5:16–20.Search in Google Scholar

24. Zeng G-F, Zhang Z-Y, Lu L, Xiao D-Q, Zong S-H, He J-M. Protective effects of ginger root extract on Alzheimer disease-induced behavioral dysfunction in rats. Rejuvenation Res. 2013;16:124–133.10.1089/rej.2012.1389Search in Google Scholar PubMed

25. Grzanna R, Phan P, Polotsky A, Lindmark L, Frondoza CG. Ginger extract inhibits β-amyloid peptide-induced cytokine and chemokine expression in cultured THP-1 monocytes. J Altern Complement Med. 2004;10:1009–1013.10.1089/acm.2004.10.1009Search in Google Scholar PubMed